Trademark: 86481019
Status Date
Monday, September 5, 2016
Filing Date
Monday, December 15, 2014
Published for Opposition
Tuesday, June 9, 2015
Abandoned Date
Monday, September 5, 2016
5 Oral, Transdermal, Injectable and Intravaginal Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics, Antifungals, Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Excluding pharmaceuticals for the diagnosis and/or treatment of diabetes
Sep 6, 2016
Abandonment Notice Mailed - No Use Statement Filed
Sep 5, 2016
Abandonment - No Use Statement Filed
Mar 9, 2016
Automatic Update Of Assignment Of Ownership
Feb 4, 2016
Notice Of Approval Of Extension Request E-Mailed
Feb 3, 2016
Extension 1 Granted
Dec 18, 2015
Extension 1 Filed
Feb 2, 2016
Case Assigned To Intent To Use Paralegal
Dec 18, 2015
Teas Extension Received
Aug 4, 2015
Noa E-Mailed - Sou Required From Applicant
Jun 9, 2015
Official Gazette Publication Confirmation E-Mailed
Jun 9, 2015
Published For Opposition
May 20, 2015
Notification Of Notice Of Publication E-Mailed
May 6, 2015
Law Office Publication Review Completed
May 6, 2015
Assigned To Lie
Apr 14, 2015
Approved For Pub - Principal Register
Apr 8, 2015
Teas/Email Correspondence Entered
Apr 8, 2015
Correspondence Received In Law Office
Apr 8, 2015
Teas Response To Office Action Received
Mar 27, 2015
Notification Of Non-Final Action E-Mailed
Mar 27, 2015
Non-Final Action E-Mailed
Mar 27, 2015
Non-Final Action Written
Mar 25, 2015
Assigned To Examiner
Dec 19, 2014
New Application Office Supplied Data Entered In Tram
Dec 18, 2014
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
